Delayed Administration of ??-Melanocyte-Stimulating Hormone or Combined Therapy with Bay 11-7085 Protects Against Gut Ischemia???Reperfusion Injury

scientific article published on 01 November 2003

Delayed Administration of ??-Melanocyte-Stimulating Hormone or Combined Therapy with Bay 11-7085 Protects Against Gut Ischemia???Reperfusion Injury is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.SHK.0000091205.08003.FD
P953full work available at URLhttps://journals.lww.com/shockjournal/Fulltext/2003/11000/Delayed_Administration_of___Melanocyte_Stimulating.13.aspx
https://journals.lww.com/10.1097/01.shk.0000091205.08003.fd
P698PubMed publication ID14560113

P2093author name stringNorio Sato
Lei Zou
Bruce C. Kone
Bashir O. Attuwaybi
P2860cites workAmerican Journal of PhysiologyQ2160146
Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemiaQ50200250
Recovery from peripheral nerve transection is accelerated by local application of alpha-MSH by means of microporous Accurel polypropylene tubesQ69572863
Physiologic concentrations of TNFalpha and IL-1beta released from reperfused human intestine upregulate E-selectin and ICAM-1Q71139832
Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alphaQ71513462
Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisalQ71537631
Ischemic Time-Dependent Microvascular Changes and Reperfusion Injury in the Rat Small IntestineQ71964479
Molecular and functional contractile sequelae of rat intestinal ischemia/reperfusion injuryQ73207707
Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patientsQ73841414
The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cellsQ74062813
Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injuryQ74118040
Splanchnic origin of cytokines in a porcine model of mesenteric ischemia-reperfusionQ74147705
Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6Q77293150
Role of constitutive nitric oxide synthase and peroxynitrite production in a rat model of splanchnic artery occlusion shockQ77309271
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuliQ24568220
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activityQ27860643
Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinasesQ28202880
NF-kappaB activation and inhibition: a reviewQ28217099
Missing pieces in the NF-kappaB puzzleQ29547864
Alpha-melanocyte stimulating hormone promotes regrowth of injured axons in the adult rat spinal cordQ31349986
Post-injury multiple organ failure: the role of the gut.Q34151557
Mucosal lesions in the human small intestine in shockQ34477401
Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammationQ37354505
Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and ratsQ37364883
Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stressQ40831600
New physiological importance of two classic residual products: carbon monoxide and bilirubinQ41565247
Nitric oxide directly impairs intestinal barrier function.Q42169145
Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shockQ43816368
Intestinal preconditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1.Q44066897
Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injuryQ44093372
NO upregulation of a cyclic nucleotide-gated channel contributes to calcium elevation in endothelial cellsQ44133772
Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injuryQ44238458
Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivoQ47070611
The influence of ischemia/reperfusion injury on the jejunum.Q47925490
Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide alpha-MSH.Q47966638
Intraischemic hypothermia differentially modulates oxidative stress proteins during mesenteric ischemia/reperfusionQ48490456
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectreperfusion injuryQ1413991
emergency medicineQ2861470
P304page(s)469-475
P577publication date2003-11-01
P1433published inShockQ7499831
P1476titleDelayed administration of alpha-melanocyte-stimulating hormone or combined therapy with BAY 11-7085 protects against gut ischemia-reperfusion injury
Delayed Administration of ??-Melanocyte-Stimulating Hormone or Combined Therapy with Bay 11-7085 Protects Against Gut Ischemia???Reperfusion Injury
P478volume20

Reverse relations

cites work (P2860)
Q36254148Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers
Q43065102Effects of Ukrain on intestinal apoptosis caused by ischemia-reperfusion injury in rats
Q38005251Melanocortins as potential therapeutic agents in severe hypoxic conditions
Q34333527Protective effect of alpha-melanocyte-stimulating hormone (α-MSH) on the recovery of ischemia/reperfusion (I/R)-induced retinal damage in a rat model.
Q33712488Targeting Iron Homeostasis in Acute Kidney Injury
Q64115665The role of PI3K/Akt signal pathway in the protective effects of propofol on intestinal and lung injury induced by intestinal ischemia/reperfusion1

Search more.